Genprex, Inc.

Analysis for Ticker: GNPX

Genprex Inc is a medical research group that promises to fix cancer and diabetes with gene therapy. But while the science is for the mice the money is for the bosses. They have burned through 167,0$ million without selling one product. To keep the money flowing they have crushed their stock two thousand times in less than two years to make the price look high while they print more paper to sell. It is a machine that takes cash from strangers to pay insiders and brokers while the original owners lose everything. The machine began before the current operators even took over. In 2023 the former chief executive Rodney Varner extracted 1,68$ million before his passing. He tied the company to a personal entity called Introgen Research Institute which guarantees his descendants a 1,0% royalty on sales for twenty-one years. This ensures that even if the company ever succeeds a family trust takes a cut before one regular person sees any money. To fund this operation the company set up a mechanism on 13/12/2023 with a broker called HC Wainwright. They created an agreement to continuously sell up to 75,0$ million in newly printed shares into the market.